Trials / Completed
CompletedNCT02076503
Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- St. Olavs Hospital · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Prostate cancer is the most frequent cancer in Norwegian men. For optimal treatment, accurate staging of the disease at the time point of diagnosis is important. The objective of this study is to evaluate the diagnostic potential of a combined PET/MR examination for risk assessment and detection of lymph node metastases. The overall aim of the project is to improve the investigators ability to provide individually tailored treatment to prostate cancer patients. The study will include 32 men with high-risk prostate cancer, who are eligible for radical prostatectomy. Informed consent is a requirement for inclusion in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PET-MR 18f-FACBC | |
| PROCEDURE | histology (gold standard) | histopathological classification of co-located dissected lymph nodes |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2014-03-03
- Last updated
- 2018-01-05
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT02076503. Inclusion in this directory is not an endorsement.